Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for prevention of succinylcholine-induced fasciculation and postoperative myalgia in elective laparotomy
PACTR202002851765619Phase 4Not yet recruiting
- Sponsor
- Dilla University
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lidocaine in Postoperative myalgia (POM) (2 arms), sponsored by Dilla University. Primary endpoint: Incidence of post-operative myalgia. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Postoperative myalgia (POM)
Beyond the preview
Go deeper on PACTR202002851765619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202002851765619.